Kadu Nivedita A, Shiragur Shobha
Department of Obstetrics and Gynaecology, Shri B.M. Patil Medical College, Hospital and Research Institute, Vijayapura, IND.
Cureus. 2023 Sep 6;15(9):e44772. doi: 10.7759/cureus.44772. eCollection 2023 Sep.
Introduction Induction of labor implies stimulation of contractions before the spontaneous onset of labor, with or without membranes. Augmentation refers to the enhancement of spontaneous contractions that are considered inadequate because of failed cervical and fetal descent. This study compared the effectiveness of intracervical Foley catheter insertion and vaginal misoprostol versus only vaginal misoprostol in the induction of labor and other outcomes relted to it. Methods The present study was a randomized controlled trial that included 148 women divided into two groups: (i) Group A, which received intracervical Foley catheter insertion and vaginal misoprostol (25 µg), and (ii) Group B, which received intravaginal administration of tablet misoprostol (25 µg) alone. We compared the median time from the time of induction to vaginal delivery, incidence of cesarean delivery, chorioamnionitis, puerperal infection, uterine tachysystole, neonatal information at delivery, and discharge status (i.e., birth weight, neonatal intensive care unit (NICU) admission, and neonatal death) between groups. Results We found that the rates of puerperal infection (n=36; 48.6%) and meconium-stained amniotic fluid (n=45; 60.8%) were higher in Group B than in Group A (n=20; 27.0% and n=25; 33.8%, respectively), which were statistically significant differences (p=0.0066 and p=0.0009, respectively). In addition, NICU admission was higher in Group B (n=47; 63.5%) than in Group A (n=30; 40.5%), which was a statistically significant difference (p=0.0051). Conclusion An intracervical Foley catheter with 25 µg of misoprostol was more effective for induction of labor than 25 µg of intravaginal misoprostol alone every six hours for a maximum of four doses in terms of induction to delivery interval, meconium-stained amniotic fluid, mode of delivery, intrapartum complications, and puerperal infection.
引言 引产是指在自然临产发动之前刺激宫缩,胎膜可破也可不破。产程加强是指增强那些因宫颈扩张和胎儿下降失败而被认为不足的自发宫缩。本研究比较了宫颈内放置 Foley 导管联合阴道用米索前列醇与单纯阴道用米索前列醇在引产及其他相关结局方面的有效性。
方法 本研究为一项随机对照试验,纳入了 148 名妇女,分为两组:(i)A 组,接受宫颈内放置 Foley 导管及阴道用米索前列醇(25μg);(ii)B 组,仅接受阴道内给予米索前列醇片(25μg)。我们比较了两组从引产到阴道分娩的中位时间、剖宫产率、绒毛膜羊膜炎、产褥感染、子宫收缩过速、分娩时的新生儿情况以及出院状态(即出生体重、新生儿重症监护病房(NICU)入院情况和新生儿死亡)。
结果 我们发现,B 组的产褥感染率(n = 36;48.6%)和羊水粪染率(n = 45;60.8%)高于 A 组(分别为 n = 20;27.0%和 n = 25;33.8%),差异具有统计学意义(分别为 p = 0.0066 和 p = 0.0009)。此外,B 组的 NICU 入院率(n = 47;63.5%)高于 A 组(n = 30;40.5%),差异具有统计学意义(p = 0.0051)。
结论 在引产至分娩间隔、羊水粪染、分娩方式、产时并发症和产褥感染方面,宫颈内放置 25μg 米索前列醇的 Foley 导管比每 6 小时单纯阴道用 25μg 米索前列醇最多 4 剂更有效地引产。